Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Renal Cell 27Neoplasms 14Neoplasm Metastasis 14Glioblastoma 14Prostatic Neoplasms 13Lymphoma, Mantle-Cell 11Breast Neoplasms 11Brain Neoplasms 11Sarcoma 10Lymphoma, Non-Hodgkin 10Kidney Neoplasms 10Endometrial Neoplasms 10Melanoma 9Gliosarcoma 8Multiple Myeloma 7Glioma 7Ovarian Neoplasms 6Carcinoma, Hepatocellular 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Oligodendroglioma 5Lymphoma, Follicular 5Lymphoma 5Hodgkin Disease 5Central Nervous System Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Astrocytoma 5Waldenstrom Macroglobulinemia 4Uterine Cervical Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 4Rhabdomyosarcoma 4

Interventions

Etoposide 10Cisplatin 7Carboplatin 6tislelizumab 2camrelizumab 2atezolizumab 2anlotinib 2Topotecan 2Irinotecan 2Drug Therapy 2Bevacizumab 2temsirolimus 1spartalizumab 1oblimersen 1obinutuzumab 1lutetium Lu 177 dotatate 1gossypol acetic acid 1durvalumab 1ceralasertib 1apatinib 1Temozolomide 1Sirolimus 1Podophyllotoxin 1Platinum 1Paclitaxel 1NVP-BKM120 1Injections 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1EC regimen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Extensive Stage Small Cell Lung Cancer × temsirolimus × Clear all
NCT00028028 2013-02-28

CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
80 enrolled
Thoracic

Extensive Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡